CDA gene polymorphisms and enzyme activity: genotype-phenotype relationship in an Italian-Caucasian population (Q39423650)

11 September 2017

title

CDA gene polymorphisms and enzyme activity: genotype-phenotype relationship in an Italian-Caucasian population (English)

1 reference

11 September 2017

0 references

2

1 reference

11 September 2017

Valerio Napolioni

8

0 references

author name string

Francesco M Carpi

1

1 reference

11 September 2017

Jessica Ubaldi

3

1 reference

11 September 2017

Stefania Pucciarelli

4

1 reference

11 September 2017

Valeria Polzonetti

5

1 reference

11 September 2017

Daniela Micozzi

6

1 reference

11 September 2017

Fiorenzo Mignini

7

1 reference

11 September 2017

publication date

1 May 2013

1 reference

11 September 2017

1 reference

11 September 2017

volume

14

1 reference

11 September 2017

issue

7

1 reference

11 September 2017

page(s)

769-781

1 reference

Cytidine deaminase residual activity in serum is a predictive marker of early severe toxicities in adults after gemcitabine-based chemotherapies

11 September 2017

cites work

1 reference

Cytidine deaminase genetic variants influence RNA expression and cytarabine cytotoxicity in acute myeloid leukemia

21 January 2018

1 reference

Identification of functional single nucleotide polymorphism haplotypes in the cytidine deaminase promoter

21 January 2018

1 reference

Correlation of cytidine deaminase polymorphisms and activity with clinical outcome in gemcitabine-/platinum-treated advanced non-small-cell lung cancer patients.

21 January 2018

1 reference

Cytidine deaminase genotype and toxicity of cytosine arabinoside therapy in children with acute myeloid leukemia

21 January 2018

1 reference

Ethnic differences of two non-synonymous single nucleotide polymorphisms in CDA gene

21 January 2018

1 reference

High-resolution melting analysis of sequence variations in the cytidine deaminase gene (CDA) in patients with cancer treated with gemcitabine

21 January 2018

1 reference

Rapid allele-specific PCR method for CDA 79A>C (K27Q) genotyping: a useful pharmacogenetic tool and world-wide polymorphism distribution.

21 January 2018

1 reference

Homozygous CDA*3 is a major cause of life-threatening toxicities in gemcitabine-treated Japanese cancer patients

21 January 2018

1 reference

Identification and analysis of single-nucleotide polymorphisms in the gemcitabine pharmacologic pathway

21 January 2018

1 reference

Severe drug toxicity associated with a single-nucleotide polymorphism of the cytidine deaminase gene in a Japanese cancer patient treated with gemcitabine plus cisplatin

21 January 2018

1 reference

Determination of plasma cytidine deaminase activity by HPLC.

21 January 2018

1 reference

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

21 January 2018

1 reference

PCR-based methods for CDA K27Q and A70T genotyping: genotypes and alleles distribution in a central Italy population

21 January 2018

1 reference

Recombinant human cytidine deaminase: expression, purification, and characterization

21 January 2018

1 reference

Modulation of human cytidine deaminase by specific aminoacids involved in the intersubunit interactions

21 January 2018

1 reference

Haploview: analysis and visualization of LD and haplotype maps

21 January 2018

1 reference

A comparison of bayesian methods for haplotype reconstruction from population genotype data

21 January 2018

1 reference

Comparison of type I error for multiple test corrections in large single-nucleotide polymorphism studies using principal components versus haplotype blocking algorithms

21 January 2018

1 reference

G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences

21 January 2018

1 reference

The structure of haplotype blocks in the human genome

21 January 2018

1 reference

Distribution of recombination crossovers and the origin of haplotype blocks: the interplay of population history, recombination, and mutation

21 January 2018

1 reference

A polymorphism in the cytidine deaminase promoter predicts severe capecitabine-induced hand-foot syndrome

21 January 2018

1 reference

Toxic death case in a patient undergoing gemcitabine-based chemotherapy in relation with cytidine deaminase downregulation

21 January 2018

1 reference

Increased CDA expression/activity in males contributes to decreased cytidine analog half-life and likely contributes to worse outcomes with 5-azacytidine or decitabine therapy

21 January 2018

1 reference

Correlation of CDA, ERCC1, and XPD polymorphisms with response and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients.

21 January 2018

1 reference

Correlation between cytidine deaminase genotype and gemcitabine deamination in blood samples

21 January 2018

1 reference

Pharmacogenomics of gemcitabine metabolism: functional analysis of genetic variants in cytidine deaminase and deoxycytidine kinase

21 January 2018

1 reference

A functional single-nucleotide polymorphism in the human cytidine deaminase gene contributing to ara-C sensitivity.

21 January 2018

1 reference

Impact of cytidine deaminase polymorphisms on toxicity after gemcitabine: the question is still ongoing.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/PGS.13.56

1 reference

release_2pfnasnnkfcqvipdgstbkpg2ta

11 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2pfnasnnkfcqvipdgstbkpg2ta

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference